Summary:

Increment:

CLIA Kit for Interleukin 24 (IL24)

SCC064Ra | Rattus norvegicus (Rat)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
Recombinant Interleukin 24 (IL24)

RPC064Ra01 | Rattus norvegicus (Rat)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
Polyclonal Antibody to Interleukin 24 (IL24)

PAC064Ra01 | Rattus norvegicus (Rat)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
Biotin-Linked Polyclonal Antibody to Interleukin 24 (IL24)

LAC064Hu71 | Homo sapiens (Human)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
Biotin-Linked Polyclonal Antibody to Interleukin 24 (IL24)

LAC064Ra71 | Rattus norvegicus (Rat)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
Polyclonal Antibody to Interleukin 24 (IL24)

PAC064Mu02 | Mus musculus (Mouse)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
Monoclonal Antibody to Interleukin 24 (IL24)

MAC064Ra21 | Rattus norvegicus (Rat)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
Recombinant Interleukin 24 (IL24)

RPC064Mu02 | Mus musculus (Mouse)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
Active Interleukin 24 (IL24)

APC064Hu01 | Homo sapiens (Human)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
Mini Samples ELISA Kit for Interleukin 24 (IL24)

MEC064Mu | Mus musculus (Mouse)

C49A; FISP; IL10B; MDA7; Mob-5; ST16; Mda-7; Melanoma Differentiation Association Protein 7; Suppression Of Tumorigenicity 16
2/3 < > 123